Entrada Therapeutics, Inc. (TRDA) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
2025-08-06 • Google News
Entrada Therapeutics Inc (TRDA)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 194.75M
P/E Ratio
0.00
Revenue (TTM)
$ 79.48M
Volume
0
52W High
$ 21.79
52W Low
$ 4.93
Dividend Yield
0.00%
Beta
-0.13
Technicals
50-Day MA
5.8252
200-Day MA
10.0937
52 Week High
21.79
52 Week Low
4.93
About TRDA
Entrada Therapeutics, Inc., a clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases.
Employees
183
Headquarters
Boston, MA
CEO
Mr. Dipal Doshi